As a subscriber to Health Canada’s MedEffectTM e-Notice, you are being informed of the latest Health Professional Communication.
http://hc-sc.gc.ca/dhp-mps/medeff/ad.../index-eng.php
Potential Risk of Serious Adverse Health Consequences with Inadvertent Administration of Cesamet (nabilone) Capsules 1 mg Instead of Trazorel (trazodone hydrochloride) Tablets 50 mg Due to Mislabelling - Valeant Canada Limited
A bottle containing Cesamet capsules 1 mg, a controlled substance used to treat nausea linked to chemotherapy, was mislabelled as Trazorel 50 mg tablets, an antidepressant. Given the health risks, 5 lots of these 2 products are subject to a recall type I.
MsL